(-0.03%) 5 467.77 points
(-0.04%) 39 098 points
(0.26%) 17 763 points
(-0.53%) $80.40
(-4.32%) $2.64
(-0.85%) $2 311.00
(-0.05%) $28.86
(2.27%) $1 008.80
(0.27%) $0.936
(0.69%) $10.68
(0.47%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States...
Stats | |
---|---|
Today's Volume | 534 999 |
Average Volume | 0 |
Market Cap | 505.68M |
EPS | $-0.470 ( Q2 | 2022-08-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-1.762 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.356 (7.67%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-09-01 | Hering David | Buy | 8 000 | Common Stock |
2022-08-17 | M28 Capital Management Lp | Buy | 584 451 | Common Stock |
2022-07-05 | Hering David | Buy | 2 000 000 | Stock Option (Right to Buy) |
2022-06-22 | Meanwell Clive | Buy | 150 000 | Stock Option (Right to Buy) |
2022-06-22 | Berry Tamsin | Buy | 150 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 73 transactions |
Buy: 92 517 480 | Sell: 27 506 245 |
Volume Correlation
Adagio Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Adagio Therapeutics, Inc. Correlation - Currency/Commodity
Adagio Therapeutics, Inc. Financials
Annual | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.04 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.04 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Adagio Therapeutics, Inc.
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company\'s lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators